title: Interstitial myofibroblasts: predictors of progression in membranous nephropathy.
abstract: OBJECTIVE
  To determine the role of interstitial myofibroblasts in the progression of membranous nephropathy; and to assess the predictive value of quantifying myofibroblasts in determining long term renal outcome.
  
  
  METHODS
  All cases of membranous nephropathy, diagnosed by renal biopsy at University Hospital of South Manchester between 1984 and 1987, were studied retrospectively. The biopsy specimens (n = 26) were reviewed and analysed morphometrically to measure interstitial volume as a proportion of the total volume of renal cortex, and numbers of interstitial myofibroblasts (cells positive for alpha-smooth muscle actin within the interstitium). Clinical data, with a follow up of seven to eight years, was available for 24 patients, and renal outcome was correlated with pathological changes in the initial diagnostic biopsy specimen.
  
  
  RESULTS
  The number of myofibroblasts and interstitial volume were inversely correlated with creatinine clearance at the initial biopsy, and at the end of follow up. Percentage sclerosed glomeruli or stage of glomerular disease, assessed by electron microscopy, did not correlate with renal function at initial biopsy or during follow up. The number of myofibroblasts, but not interstitial volume, correlated with severity of proteinuria at initial biopsy. Of 15 biopsy specimens showing no or mild interstitial fibrosis, four showed a notable increase in the number of interstitial myofibroblasts. All of these patients developed chronic renal failure, compared with three of 11 patients whose specimens showed no or a mild increase in myofibroblast numbers.
  
  
  CONCLUSIONS
  Interstitial myofibroblasts play a role in the development of interstitial fibrosis and progressive renal failure in membranous nephropathy. Increased numbers of myofibroblasts in biopsy specimens showing only mild fibrosis may predict subsequent chronic renal failure.
authors.affiliation: Department of Pathological Sciences, University of Manchester, USA.
authors.forename: I S
authors.initials: IS
authors.lastname: Roberts
authors.forename: C
authors.initials: C
authors.lastname: Burrows
authors.forename: J H
authors.initials: JH
authors.lastname: Shanks
authors.forename: M
authors.initials: M
authors.lastname: Venning
authors.forename: L J
authors.initials: LJ
authors.lastname: McWilliam
mesh_terms: D000199:Actins / Q000378:metabolism; D000293:Adolescent; D000328:Adult; D000368:Aged; D001706:Biopsy; D003404:Creatinine / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D005347:Fibroblasts / Q000378:metabolism / Q000473:pathology*; D005500:Follow-Up Studies; D015433:Glomerulonephritis, Membranous / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009130:Muscle, Smooth / Q000378:metabolism / Q000473:pathology*; D011237:Predictive Value of Tests; D051437:Renal Insufficiency / Q000473:pathology; D012189:Retrospective Studies
chemical_list: D000199:Actins; D003404:Creatinine